Literature DB >> 9443637

Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells.

S M Konstantinov1, H Eibl, M R Berger.   

Abstract

Alkylphosphocholines (APC) represent a new group of ether-lipid-related compounds with remarkable activity against transformed cells in vitro and good tolerability in vivo. Their mechanism of action remains unknown. The aim of the present study was to investigate the effects of a series of APC on three human leukemic cell lines: K-562, HL-60, and U-937. The tetrazolium dye-reduction (MTT) assay and cell counting were used to determine the cytotoxicity of the APC used. DNA gel electrophoresis and enzyme-linked immunosorbent assay (ELISA) detection of oligonucleosomes were performed to identify and quantify DNA fragmentation. Electron and phase-contrast microscopy were used to detect morphologic changes specific for programmed cell death. HL-60 and U-937 cells were found to be sensitive, but K-562 cells were relatively resistant to APC exposure. APC with long alkyl chains exerted stronger cytotoxicity than did those with short alkyl chains. DNA fragmentation was found after treatment with APC in HL-60 and U-937 cells but not in K-562 cells. In HL-60 cells the increase in mono- and oligonucleosome formation as measured by ELISA was correlated with the length of the alkyl chains at 14 h of exposure to APC but plateaued at 20 h. The morphologic alterations in HL-60 and U-937 cell lines, such as cell shrinkage, chromatin condensation, and formation of apoptotic bodies, confirmed the induction of apoptosis after APC exposure. It is concluded that programmed cell death plays an important role in the cytotoxicity of APC against certain human leukemic cell lines. The antineoplastic profiles of APC with long alkyl chains render them attractive for further therapeutic application.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443637     DOI: 10.1007/s002800050730

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

Review 1.  PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes.

Authors:  Ipsita Pal; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

2.  Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.

Authors:  C Cabaner; C Gajate; A Macho; E Muñoz; M Modolell; F Mollinedo
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Distinct roles of the 7-transmembrane receptor protein Rta3 in regulating the asymmetric distribution of phosphatidylcholine across the plasma membrane and biofilm formation in Candida albicans.

Authors:  Archita Srivastava; Shabnam Sircaik; Farha Husain; Edwina Thomas; Shivani Ror; Sumit Rastogi; Darakshan Alim; Priyanka Bapat; David R Andes; Clarissa J Nobile; Sneh L Panwar
Journal:  Cell Microbiol       Date:  2017-10-04       Impact factor: 3.715

4.  Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.

Authors:  Julia Walochnik; Michael Duchêne; Karin Seifert; Andreas Obwaller; Thomas Hottkowitz; Gerhard Wiedermann; Hansjörg Eibl; Horst Aspöck
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.

Authors:  Ilina K Dineva; Maya M Zaharieva; Spiro M Konstantinov; Hansjörg Eibl; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-30       Impact factor: 4.553

6.  Electrodelivery of drugs into cancer cells in the presence of poloxamer 188.

Authors:  Iana Tsoneva; Iordan Iordanov; Annette J Berger; Toma Tomov; Biliana Nikolova; Nikola Mudrov; Martin R Berger
Journal:  J Biomed Biotechnol       Date:  2010-07-25

7.  Possible mechanism of miltefosine-mediated death of Leishmania donovani.

Authors:  Navin K Verma; Chinmoy S Dey
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs.

Authors:  Michael Fiegl; Lars H Lindner; Matthias Juergens; Hansjoerg Eibl; Wolfgang Hiddemann; Jan Braess
Journal:  Cancer Chemother Pharmacol       Date:  2007-10-06       Impact factor: 3.333

9.  Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress.

Authors:  Marcus Dymond; George Attard; Anthony D Postle
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

10.  The effect of edelfosine on GRA1 and MIC3 expressions in acute toxoplasmosis.

Authors:  Asal Tanzifi; Amirhosein Khoshi; Saeed Emami; Shahabeddin Sarvi; Mehdi Sharif; Mahbobeh Montazeri; Meysam Moghbeli; Ahmad Daryani
Journal:  Parasitol Res       Date:  2020-01-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.